View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
A medication that stimulates normal growth hormone secretion could help stave off physical weakness or frailty in older patients, researchers report. As people age, declining levels of growth hormone may contribute to the loss of muscle mass, contributing to frailty. Given orally, an experimental oral drug known as MK-677 seems to restore growth hormone levels.
In a study, 65 healthy adults ages 60 to 81 received either MK-677 or a placebo once daily for 1 year. Then the participants who received placebo started taking the drug and those who received the drug during the first year were randomly assigned to continue receiving it or to receive placebo instead.
In participants receiving MK-677, growth hormone levels increased to those of healthy young adults, resulting in an increase in fat-free mass (most of which was muscle). Their appetites increased and body weight rose by 5.9 pounds (2.7 kg), compared with 1.8 pounds (0.8 kg) while taking placebo. Loss of muscle mass and decreased appetite are hallmarks of frailty. However, the treatment, which was generally "well tolerated," didn't improve participants' muscle strength or function.
Researchers recommend long-term studies with more participants to investigate clinical benefits and costs associated with the treatment.
Source: Nass R, Pezzoli SS, Oliveri MC, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults. Ann Intern Med. 2008;149(9): 601-611.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top